Forte Biosciences (FBRX) EBIT Margin (2017 - 2019)
Forte Biosciences' EBIT Margin came in at -17377.78% for Q4 2019, up 194933.33 percentage points from -212311.11% a year earlier but down 9777.78 percentage points from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) EBIT Margin (2017 - 2019) Analysis & Trends
For FY2019, Forte Biosciences' EBIT Margin was -11288.89%, down 11034.66 percentage points from FY2018.
- EBIT Margin carries a three-year change of +53384.58 percentage points (FY2016 to FY2019).
- Going back by year, EBIT Margin was -254.23% in FY2018 (+91521.38 pp), -91775.61% in FY2017 (-27102.14 pp) and -64673.47% in FY2016.
- The five-year range for quarterly EBIT Margin is -212311.11% (Q4 2018) to 7.92% (Q3 2018).
- Year-over-year, EBIT Margin increased in three of the last seven quarters, with an average year-over-year change of +30581.59 percentage points.
- Business Quant data shows FBRX's EBIT Margin at -7600.00% (Q3 2019), -6988.89% (Q2 2019) and -187455.56% (Q1 2019) in the three quarters before Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -17,377.78% |
| Sep 30, 2019 | -7,600.00% |
| Jun 30, 2019 | -6,988.89% |
| Mar 31, 2019 | -187,455.56% |
| Dec 31, 2018 | -212,311.11% |
| Sep 30, 2018 | 7.92% |
| Jun 30, 2018 | -170,300.00% |
| Mar 31, 2018 | -142,733.33% |
| Dec 31, 2017 | -106,870.00% |
| Sep 30, 2017 | -97,370.00% |
| Jun 30, 2017 | -86,520.00% |
API Access
Forte Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();